HomeCannabis

    Cannabis

    CNBX Peer-reviewed Study: “Possible Future Therapeutic Value” for CNBX Proprietary Drug Candidate

    CNBX Peer-reviewed Study: "Possible Future Therapeutic Value" for CNBX Proprietary Drug Candidate PR Newswire ...

    Heritage Cannabis Announces Second Amendment to Senior Secured Loan and a Facility Increase to $19.775 Million

    Toronto, ON, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) (“Heritage” or the “Company”), today announced that it has entered into a second loan amending agreement (the “ ...

    Grown Rogue Reports Third Quarter 2022 Results, Positive Free Cash Flow and Net Income

    Grown Rogue Reports Third Quarter 2022 Results, Positive Free Cash Flow and Net Income Canada NewsWire ...

    FIRST-EVER TOM’S OF MAINE INCUBATOR TO ELEVATE NEXT GENERATION OF BIPOC ENVIRONMENTAL LEADERS

    FIRST-EVER TOM'S OF MAINE INCUBATOR TO ELEVATE NEXT GENERATION OF BIPOC ENVIRONMENTAL LEADERS PR Newswire ...

    Keep exploring

    Grown Rogue Reports Third Quarter 2022 Results, Positive Free Cash Flow and Net Income

    Grown Rogue Reports Third Quarter 2022 Results, Positive...

    FIRST-EVER TOM’S OF MAINE INCUBATOR TO ELEVATE NEXT GENERATION OF BIPOC ENVIRONMENTAL LEADERS

    FIRST-EVER TOM'S OF MAINE INCUBATOR TO ELEVATE NEXT...

    CNBX Pharmaceuticals Announces New Patent Granted in Australia

    CNBX Pharmaceuticals Announces New Patent Granted in Australia ...

    SCHWAZZE OPENS NEW CANNABIS DISPENSARY IN RUIDOSO

    SCHWAZZE OPENS NEW CANNABIS DISPENSARY IN RUIDOSO ...

    Zynerba Pharmaceuticals to Participate in the Cantor Neurology & Psychiatry Conference

    DEVON, Pa., Sept. 29, 2022 (GLOBE NEWSWIRE) -- ...

    AXIM® Biotechnologies Point-of-Care Diagnostic Test Platform Sales Commence With Verséa Ophthalmics’ Commercial Launch at AAO 2022

    Sales of Point-of-Care Diagnostic Tests for Ocular Surface Disease Commence at the American Academy...

    Cara Therapeutics Announces Difelikefalin (KORSUVA®) Injection New Drug Application Has Been Submitted in Japan

    STAMFORD, Conn., Sept. 28, 2022 (GLOBE NEWSWIRE) -- Cara...

    Canopy Growth Announces Divestiture of Canadian Retail Operations

    Canopy Growth Announces Divestiture of Canadian Retail Operations ...

    CV Sciences, Inc. Announces Proposed Settlement of Shareholder Litigation

    CV Sciences, Inc. Announces Proposed Settlement of Shareholder...

    ePlus Achieves Palo Alto Networks Authorized Support Center Certified Partner Status

    ePlus Achieves Palo Alto Networks Authorized Support Center...

    Latest News

    CNBX Peer-reviewed Study: “Possible Future Therapeutic Value” for CNBX Proprietary Drug Candidate

    CNBX Peer-reviewed Study: "Possible Future Therapeutic Value" for...

    Heritage Cannabis Announces Second Amendment to Senior Secured Loan and a Facility Increase to $19.775 Million

    Toronto, ON, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Heritage...

    Grown Rogue Reports Third Quarter 2022 Results, Positive Free Cash Flow and Net Income

    Grown Rogue Reports Third Quarter 2022 Results, Positive...

    FIRST-EVER TOM’S OF MAINE INCUBATOR TO ELEVATE NEXT GENERATION OF BIPOC ENVIRONMENTAL LEADERS

    FIRST-EVER TOM'S OF MAINE INCUBATOR TO ELEVATE NEXT...